Sponsored by BaseLaunch 7 Mar 2023Basel: It Takes an Ecosystem to Build a Startup Europe has a number of bubbling biotech hubs that offer access to expertise, financial support, and networking opportunities for young… March 7, 2023 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Reports by Medpace 28 Jul 2022A toolkit for emerging biotechs: practical advice for navigating challenges and advancing clinical development By 2030, the global biotech industry is expected to reach a market value of $1,684B. At the forefront of the… July 28, 2022 - 1 minutemin - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Sponsored by Collaborative Drug Discovery Inc. 15 Mar 2022How Managing Data Effectively Helps Fight Antimicrobial Resistance Collaborative Drug Discovery The crisis of antibiotic resistance is making the discovery and development of new antibiotics crucial, and companies… March 15, 2022 - 9 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Infographics by WuXi AppTec 1 Mar 2022Infographic: Drugging the Undruggable: Leveraging the Right Screening Methods for Challenging Targets Challenging targets, such as membrane proteins or protein-protein interactions were considered undruggable in the past. However, today a variety of… March 1, 2022 - 2 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Dec 2021The Billion-Euro European Biotech Companies in 2022 Here’s a list of the public European biotech companies that are worth more than a billion euros in 2022. European… December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 Jun 2021Top 15 Swiss biotech startups making a difference in Europe Switzerland has long been known as a booming biotech hotspot in Europe that boasts many high-profile companies. Here are the… June 9, 2021 - 11 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 31 May 2021What’s Ahead for European Biotech Startups After Covid? With a tumultuous year behind us, 2021 is set out to spell change for many startups in the European biotech… May 31, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 10 May 2021The Rollercoaster of Repurposing an Arthritis Drug for Covid-19 The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs into vaccines and treatments for… May 10, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 5 Apr 2021Base Editing: The Next Frontier in Genome Editing Technology Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights into the promises of base… April 5, 2021 - 4 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 15 Mar 2021Developing a Vaccine that Protects Against Covid-19 Variants Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs around the world, recent mutations… March 15, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 3 Mar 2021The Promises of CRISPR Genome Editing in Biomedicine Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the advantages of CRISPR gene editing… March 3, 2021 - 5 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Jan 2021The 15 Best Biotech Companies in Belgium Meet the most successful biotech companies in Belgium, a small country that makes a huge contribution to the biotech industry. … January 25, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2021The 21 European Biotech Companies To Watch in 2021 As we enter 2021, the biotech industry is already bustling with activity. Here’s a list of 21 European biotech companies… January 11, 2021 - 11 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Reports by CrownBio 1 Dec 2020Report: Are Tumor Organoids the Future of Cancer Drug Development? Over the last decade, oncology drug development has been marred by the high attrition rates of new anticancer agents. These… December 1, 2020 - 3 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Reports 11 Nov 2020Navigating the Immunotherapy Maze Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to reach a staggering value of… November 11, 2020 - 2 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 28 Oct 2020Do Natural Killer Cells Hold the Key to Treating Blood Cancers? Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come with a number of setbacks,… October 28, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Infographics by Merck 26 Oct 2020Ensuring Viral Vector Supply for Gene Therapies While the success of gene therapies has boosted investments in the sector, it has also led to a number of… October 26, 2020 - 2 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 5 Oct 2020How is Germany Meeting Patient Demand for Medical Cannabis? Since Germany legalized cannabis for medical use in 2017, we have frequently spoken to Peter Homberg, Partner and Head of… October 5, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Sponsored by Biovian 28 Sep 2020What Factors can Ease the Complexity of Viral Vector Production for Gene Therapies? While the global gene therapy market grows steadily, companies continue to face bottlenecks in the production of gene therapy’s essential… September 28, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Reports 30 Jul 2020Current and Emerging Therapeutic Approaches for Autoimmune Diseases Over 4% of the world's population suffers from one or more of over 80 autoimmune diseases identified to date. A… July 30, 2020 - 3 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email